PSI Advisors’s Beta Bionics BBNX Stock Holding History

PSI Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-682	Closed	-$8.35K	–	737
2025 Q1	$8.35K	Buy	+682	New	+$12.7K	﹤0.01%	472

Other funds holding BBNX

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PSI Advisors's BBNX Position: Q2 2025 in Review

PSI Advisors sold out of Beta Bionics (BBNX) in Q2 2025, closing a stake of 682 shares — an estimated $8.35K sold.

PSI Advisors first reported a position in BBNX in Q1 2025 and held it in 1 quarter. The position peaked at $8.35K in Q1 2025. 116 funds tracked by Wall St. Rank hold BBNX as of Q2 2025.

PSI Advisors reported no remaining Beta Bionics position as of Q2 2025 after selling out during the quarter.
PSI Advisors sold 682 Beta Bionics shares in Q2 2025, an estimated $8.35K.
PSI Advisors first reported a position in Beta Bionics in Q1 2025 and held it in 1 quarter.
PSI Advisors's Beta Bionics position peaked at $8.35K in Q1 2025.
116 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.